• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈症患者语音客观有效声学特征的听众检测

Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease.

作者信息

Chan Jess C S, Stout Julie C, Shirbin Christopher A, Vogel Adam P

机构信息

Centre for Neuroscience of Speech, University of Melbourne, Victoria, Australia.

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Victoria, Australia.

出版信息

J Huntingtons Dis. 2022;11(1):71-79. doi: 10.3233/JHD-210501.

DOI:10.3233/JHD-210501
PMID:34974436
Abstract

BACKGROUND

Subtle progressive changes in speech motor function and cognition begin prior to diagnosis of Huntington's disease (HD).

OBJECTIVE

To determine the nature of listener-rated speech differences in premanifest and early-stage HD (i.e., PreHD and EarlyHD), compared to neurologically healthy controls.

METHODS

We administered a speech battery to 60 adults (16 people with PreHD, 14 with EarlyHD, and 30 neurologically healthy controls), and conducted a cognitive test of processing speed/visual attention, the Symbol Digit Modalities Test (SDMT) on participants with HD. Voice recordings were rated by expert listeners and analyzed for acoustic and perceptual speech features.

RESULTS

Listeners perceived subtle differences in the speech of PreHD compared to controls, including abnormal pitch level and speech rate, reduced loudness and loudness inflection, altered voice quality, hypernasality, imprecise articulation, and reduced naturalness of speech. Listeners detected abnormal speech rate in PreHD compared to healthy speakers on a reading task, which correlated with slower speech rate from acoustic analysis and a lower cognitive performance score. In early-stage HD, continuous speech was characterized by longer pauses, a higher proportion of silence, and slower rate.

CONCLUSION

Differences in speech and voice acoustic features are detectable in PreHD by expert listeners and align with some acoustically-derived objective speech measures. Slower speech rate in PreHD suggests altered oral motor control and/or subtle cognitive deficits that begin prior to diagnosis. Speakers with EarlyHD exhibited more silences compared to the PreHD and control groups, raising the likelihood of a link between speech and cognition that is not yet well characterized in HD.

摘要

背景

在亨廷顿舞蹈症(HD)诊断之前,言语运动功能和认知就开始出现细微的渐进性变化。

目的

确定与神经功能正常的对照组相比,临床前和早期HD(即PreHD和EarlyHD)患者在听众评定的言语差异的性质。

方法

我们对60名成年人(16名PreHD患者、14名EarlyHD患者和30名神经功能正常的对照组)进行了言语测试,并对HD患者进行了处理速度/视觉注意力的认知测试,即符号数字模态测试(SDMT)。由专业听众对语音录音进行评分,并分析声学和感知言语特征。

结果

与对照组相比,听众察觉到PreHD患者的言语存在细微差异,包括音高异常、语速异常、响度降低和响度变化、音质改变、鼻音过重、发音不清晰以及言语自然度降低。在阅读任务中,与健康说话者相比,听众发现PreHD患者的语速异常,这与声学分析得出的较慢语速以及较低的认知表现得分相关。在早期HD中,连续言语的特点是停顿时间更长、沉默比例更高以及语速更慢。

结论

专业听众可在PreHD患者中检测到言语和语音声学特征的差异,且这些差异与一些从声学得出的客观言语指标相符。PreHD患者较慢的语速表明在诊断之前就出现了口腔运动控制改变和/或细微的认知缺陷。与PreHD组和对照组相比,EarlyHD患者的沉默更多,这增加了HD中尚未得到充分表征的言语与认知之间存在联系的可能性。

相似文献

1
Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease.亨廷顿舞蹈症患者语音客观有效声学特征的听众检测
J Huntingtons Dis. 2022;11(1):71-79. doi: 10.3233/JHD-210501.
2
Speech acoustic markers of early stage and prodromal Huntington's disease: a marker of disease onset?早期和前驱亨廷顿病的言语声学标志物:疾病发病的标志物?
Neuropsychologia. 2012 Dec;50(14):3273-8. doi: 10.1016/j.neuropsychologia.2012.09.011. Epub 2012 Sep 14.
3
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.TRACK-HD 研究中在无症状和早期亨廷顿病中表型进展和疾病发作的预测因素:36 个月观察性数据的分析。
Lancet Neurol. 2013 Jul;12(7):637-49. doi: 10.1016/S1474-4422(13)70088-7. Epub 2013 May 9.
4
Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.亨廷顿病前驱期和症状期的言语障碍作为衡量显性遗传性神经退行性疾病发病和进展的模型。
Neurosci Biobehav Rev. 2019 Dec;107:450-460. doi: 10.1016/j.neubiorev.2019.08.009. Epub 2019 Aug 13.
5
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.亨廷顿病青年研究(HD-YAS)中基因携带者的生物学和临床特征:一项横断面分析。
Lancet Neurol. 2020 Jun;19(6):502-512. doi: 10.1016/S1474-4422(20)30143-5. Epub 2020 May 26.
6
Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages.亨廷顿舞蹈症的言语生物标志物:一项针对症状前、前驱期和早期显性阶段的横断面研究。
Eur J Neurol. 2023 May;30(5):1262-1271. doi: 10.1111/ene.15726. Epub 2023 Feb 22.
7
The Repeatable Battery for the Assessment of Neuropsychological Status, While Useful for Measuring Cognitive Changes in Manifest Huntington Disease, May Show Limited Utility in Premanifest Disease.重复性成套神经心理状态测验,虽然有助于测量亨廷顿病显性期的认知变化,但在疾病前期的应用可能具有一定的局限性。
Cogn Behav Neurol. 2022 Sep 1;35(3):198-203. doi: 10.1097/WNN.0000000000000310.
8
Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease.前驱基因携带者和早期亨廷顿病患者的视觉工作记忆损害
J Huntingtons Dis. 2012;1(1):97-106. doi: 10.3233/JHD-2012-120010.
9
Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease.用于量化亨廷顿病患者言语障碍的与语言无关的声学生物标志物。
Am J Speech Lang Pathol. 2024 May;33(3):1390-1405. doi: 10.1044/2024_AJSLP-23-00175. Epub 2024 Mar 26.
10
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.神经精神症状在亨廷顿舞蹈症的临床前和早期阶段非常常见。
Parkinsonism Relat Disord. 2016 Apr;25:58-64. doi: 10.1016/j.parkreldis.2016.02.008. Epub 2016 Feb 11.

引用本文的文献

1
Perceptual and Acoustic Analysis of Speech in Spinocerebellar ataxia Type 1.1 型脊髓小脑共济失调语音的感知和声学分析。
Cerebellum. 2024 Feb;23(1):112-120. doi: 10.1007/s12311-023-01513-9. Epub 2023 Jan 12.